MedTrace Logo

Distribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From Croatia

NCT01385436 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2011-06-30

No results posted yet for this study

Summary

Human papillomavirus (HPV) of high-risk genotype is a necessary risk factor in development of cervical cancer. There is a vaccine available to prevent cervical lesions associated with high-risk HPV genotypes 16 and 18. In Croatia HPV vaccination has not yet been introduced in obligatory vaccination schedule. The aim of this study is to describe the pre-vaccination distribution of HPV genotypes in women with high grade cervical squamous intraepithelial lesion (HSIL) and cervical cancer in Croatia. The investigators hypothesis is that HPV-16 is the most frequently found genotype but the distribution of other HPV genotypes is heterogeneous and includes genotypes currently not covered by vaccination.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Adriana Vince, MD, PhD · University Hospital for Infectious Diseases Zagreb, Croatia

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-12-31
Completion
2013-12-31

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01385436 on ClinicalTrials.gov